Boston Scientific is trading lower this morning, reflecting a broader trend of mild pressure within the medical device sector as peers like Medtronic also saw a 1.2% decline in the previous session.
The stock is facing additional headwinds following an announcement on November 10 that a law firm is investigating potential claims on behalf of investors. While institutional interest remains active, evidenced by Ethic Inc. increasing its position in the company by 11.1% during the third quarter, this news has been ov